Biopharmaceutical company focused on ophthalmic treatments.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FORBES-TATE |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2026 | FORBES-TATE |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2025 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | FORBES-TATE |
4th Quarter (Oct 1 - Dec 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FORBES-TATE | 4 | — |
| Issue | Activities |
|---|---|
| Health Issues | 4 |